Attention Deficit Hyperactivity Disorder(ADHD). Attention deficit: disorder with hyperactivity hyperactivity disorder syndrome with hyperactivity
Conditions
Interventions
Intervention 1: In Duloxetine group , we will prescribe this agent for 6 weeks once daily orally at night. The dose is 15 mg/d for the first week and 30 mg/d for the next 3 weeks. If needed , we will
Treatment - Drugs
In Duloxetine group , we will prescribe this agent for 6 weeks once daily orally at night. The dose is 15 mg/d for the first week and 30 mg/d for the next 3 weeks. If needed , we will increase the do
In control group, Methylphenidate ( Ritalin ) will be given 1/2 BD in first week and TDS in second week orally ( one in morning , one in afternoon and one at the evening ). Then patients will evaluate
Sponsors
University of Social Welfare and Rehabilitation Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : ADHD diagnosis according to DSM-IV-TR that is applied by two psychiatrists; age between 6-12 years old Exclusion criteria : mental retardation; history of heart disease; drug sensitivity; comorbidity of severe mental illnesses such as bipolar disorder, major depressive disorder, conduct disorder, psychosis; history of seizure.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of ADHD symtoms. Timepoint: each two weeks. Method of measurement: ADHD rating scale/ Conners rating scale-parent form. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug side effects, severity of depressive and anxiety symptoms. Timepoint: beginning and end of trial. Method of measurement: checklist of side effects- CDI-RCMAS. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNasrin Dodangi
University of Social Welfare and Rehabilitation Sciences
Outcome results
None listed